Reduced phosphorylation of MLC2v has been implicated in human heart disease where phosphorylation was reduced to ∼18% of total MLC2v in failing hearts from ∼30 to 40% in healthy hearts (Morano, 1999; van der Velden et al., 2003). The gene discussed is MYL2; the disease is heart disorder.